Gene Therapy for Rare Disorders Europe will bring together key decision makers from industry- leading pharma and biotech companies in the gene therapy space.
The potential for gene therapies is apparent, yet these drug developer organisations are telling us that they have little visibility of which CMOs, CROs and vector platform companies have the technical experience, capacity and flexibility to meet their demands.
If you have capabilities that would benefit our audience in the gene therapy space, Gene Therapy for Rare Disorders Europe provides a unique platform to:
- Showcase your solutions
- Generate new business leads
- Source opportunities for partnerships
Partnering with the only conference exclusively dedicated to the development of gene therapies will enable you to secure and expand your market share in this commercially expanding market.
Act now to stay ahead of the curve and seize the wealth of opportunities on offer.